KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA
Q+A on the latest FDA-approved non-invasive cosmetic treatment Kybella KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA™ – First FDA-Approved Injectable Treatment for “Double Chin” – Through KYBELLA™ Trained Physicians June 19, 2015 Westlake Village, Calif., June 19, 2015 — KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced the U.S. availability of KYBELLA™ (deoxycholic acid) injection, the … Continue reading KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA
View More